Relay Therapeutics (RLAY) Financials: Revenue & Earnings

RLAY price $19.47 +0.63 +3.35%

Ticker
RLAY
Price
$19.47
Change
+0.63 +3.35%
Market cap ?
$4.27B
P/E ?
-11.58
Dividend yield ?
0.00%
Beta ?
1.73
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
60
Value
47
Quality
46
Growth
88

Stocklytics score rationale: value 47, quality 46, growth 88.

Financials

20182019202020212022202320242025
008265400030290001381000255460001000700015355000

Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule…

Fair value

RLAY fair value Not meaningful. Price $19.47.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare RLAY

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.40—1.62M
2026-08-06-0.41-0.39350.00K960.00K
2026-05-05-0.41-0.353.00M5.58M
2026-02-26-0.32-0.387.00M4.97M
2025-11-06-0.43-0.39—4.96M
2025-08-07-0.41-0.49677.00K14.29K
2025-05-05-0.46-0.507.68M3.76M
2025-02-26-0.45-0.57—5.53M
2024-11-06-0.63-0.77—66.67K
2024-08-06-0.69-0.73—80.00K
2024-05-02-0.62-0.7010.01M30.00K
2024-02-22-0.67-0.761.00K130.00K
2023-11-02-0.54-0.8325.20M370.00K
2023-08-08-0.81-0.78119.00K750.00K
2023-05-04-0.78-0.70226.00K190.00K
2023-02-23-0.56-0.71253.00K271.43K
2022-11-03-0.76-0.71344.00K1.80M
2022-08-04-0.71-0.62365.00K2.08M
2022-05-05-0.61-0.63419.00K166.67K
2022-02-24-0.59-0.60567.00K3.84M
2021-11-10-0.66-0.65666.00K655.75K
2021-08-12-2.10-0.48844.00K844.00K
2021-05-13-0.47-0.48952.00K971.83K
2021-03-250.700.1782.65M—
2020-11-12-0.51-0.35——
2020-08-27-6.06-0.66——
2020-07-09-5.99———
2019-12-31-6.24———
2019-09-30-5.53———
2019-06-30-5.28———
2019-03-31-4.59———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-07Patel SanjivSell48.20K$18.10872.40K
2026-10-06Catinazzo ThomasSell17.51K$18.58325.35K
2026-10-06Catinazzo ThomasSell206$19.263.97K
2026-09-08Bergstrom Donald ASell8.53K$18.97161.81K
2026-09-08Catinazzo ThomasSell17.72K$18.94335.56K
2026-09-08Patel SanjivSell48.20K$18.94912.89K
2026-08-26Rahmer PeterSell4.51K$20.0390.30K
2026-08-25SVF Pauling (Cayman) LtdSell6.00M$19.40116.40M
2026-08-17Patel SanjivSell48.20K$20.33979.89K
2026-08-14Catinazzo ThomasSell17.72K$19.74349.73K
2026-07-28Catinazzo ThomasSell1.46K$18.6127.15K
2026-07-28Rahmer PeterSell748$18.6113.92K
2026-07-28Bergstrom Donald ASell2.24K$18.6141.63K
2026-07-07Patel SanjivSell48.20K$19.58943.74K
2026-07-06Bergstrom Donald ASell8.66K$18.71162.03K
2026-07-06Catinazzo ThomasSell17.72K$18.69331.13K
2026-06-30Patel SanjivBuy3.06K$6.9521.24K
2026-06-30Rahmer PeterBuy3.06K$6.9521.24K
2026-06-30Rahmer PeterSell50.00K$19.09954.50K
2026-06-22Catinazzo ThomasBuy61.56K$5.22321.36K
2026-06-22Catinazzo ThomasBuy56.32K$5.04283.87K
2026-06-22Catinazzo ThomasBuy51.56K$4.45229.44K
2026-06-22Catinazzo ThomasSell51.56K$4.45229.44K
2026-06-22Catinazzo ThomasSell17.72K$17.01301.37K
2026-06-22Catinazzo ThomasSell51.56K$16.97874.97K
2026-06-22Catinazzo ThomasSell56.32K$5.04283.87K
2026-06-22Catinazzo ThomasSell61.56K$5.22321.36K
2026-06-22Bergstrom Donald ABuy93.46K$4.12385.04K
2026-06-22Bergstrom Donald ASell93.46K$16.941.58M
2026-06-22Bergstrom Donald ASell93.46K$4.12385.04K
2026-06-09Mazumdar ClaireBuy32.95K$14.09464.22K
2026-06-09Dable Habib JBuy32.95K$14.09464.22K
2026-06-09HILL LINDA ABuy32.95K$14.09464.22K
2026-06-09Borisy AlexisBuy32.95K$14.09464.22K
2026-06-09INGRAM DOUGLAS SBuy32.95K$14.09464.22K
2026-06-09Murcko MarkBuy32.95K$14.09464.22K
2026-06-09COATS LONNELBuy32.95K$14.09464.22K
2026-05-14Catinazzo ThomasSell17.72K$12.86227.84K
2026-04-28Catinazzo ThomasSell972$14.7914.38K
2026-04-28Rahmer PeterSell753$14.7911.14K
2026-04-28Bergstrom Donald ASell1.49K$14.7922.04K
2026-04-09Catinazzo ThomasBuy1.80K$5.229.40K
2026-04-09Catinazzo ThomasSell1.80K$15.0027.00K
2026-04-09Catinazzo ThomasSell1.80K$5.229.40K
2026-04-07Catinazzo ThomasSell17.72K$13.01230.50K
2026-03-09Catinazzo ThomasSell17.72K$10.06178.23K
2026-01-28Bergstrom Donald ASell2.69K$8.4522.70K
2026-01-28Rahmer PeterSell1.35K$8.4511.44K
2026-01-28Catinazzo ThomasSell1.70K$8.4514.32K
2026-01-27Bergstrom Donald ASell18.89K$7.62143.98K
2026-01-27Rahmer PeterSell11.68K$7.6289.03K
2026-01-27Catinazzo ThomasSell13.82K$7.62105.31K
2026-01-13Bergstrom Donald ABuy575.00K$7.944.57M
2026-01-13Rahmer PeterBuy475.00K$7.943.77M
2026-01-13Patel SanjivBuy1.45M$7.9411.51M
2026-01-13Catinazzo ThomasBuy400.00K$7.943.18M
2026-01-06Patel SanjivSell43.17K$7.82337.57K
2025-12-31Rahmer PeterBuy994$2.992.97K
2025-12-31Patel SanjivBuy994$2.992.97K
2025-11-04COATS LONNELBuy207.93K$6.861.43M
2025-11-04Dable Habib JBuy207.93K$6.861.43M
2025-11-04COATS LONNELOther0——
2025-11-04Dable Habib JOther0——
2025-11-03Patel SanjivSell62.07K$7.00434.51K
2025-10-29Rahmer PeterSell21.39K$7.50160.46K
2025-10-28Rahmer PeterSell19.14K$7.29139.49K
2025-10-28Catinazzo ThomasSell21.66K$7.29157.93K
2025-10-28Bergstrom Donald ASell30.90K$7.29225.24K
2025-07-29Rahmer PeterSell15.72K$3.6857.86K
2025-07-29Catinazzo ThomasSell18.38K$3.6867.64K
2025-07-29Bergstrom Donald ASell26.70K$3.6898.26K
2025-07-29Adams BrianSell18.28K$3.6867.26K
2025-07-28Rahmer PeterSell1.36K$3.745.08K
2025-07-28Catinazzo ThomasSell1.70K$3.746.36K
2025-07-28Bergstrom Donald ASell4.07K$3.7415.22K
2025-07-28Adams BrianSell1.64K$3.746.12K
2025-07-09Patel SanjivSell42.74K$3.57152.58K
2025-07-09Patel SanjivSell18.64K$3.5766.54K
2025-06-30Rahmer PeterBuy5.00K$2.9414.70K
2025-06-30Patel SanjivBuy5.00K$2.9414.70K
2025-06-09Mazumdar ClaireBuy421.24K$3.361.42M
2025-06-09Mazumdar ClaireOther0——
2025-06-06HILL LINDA ABuy136.68K$3.36459.25K
2025-06-06Borisy AlexisBuy136.68K$3.36459.25K
2025-06-06INGRAM DOUGLAS SBuy136.68K$3.36459.25K
2025-06-06Kathiresan SekarBuy136.68K$3.36459.25K
2025-06-06Murcko MarkBuy136.68K$3.36459.25K
2025-06-06Rubin JamiBuy136.68K$3.36459.25K
2025-04-30Rahmer PeterSell10.74K$3.0032.22K
2025-04-30Catinazzo ThomasSell12.94K$3.0038.83K
2025-04-30Bergstrom Donald ASell27.47K$3.0082.42K
2025-04-30Adams BrianSell12.94K$3.0038.83K
2025-04-29Catinazzo ThomasSell3.56K$3.2311.49K
2025-04-28Rahmer PeterSell1.36K$3.174.32K
2025-04-28Catinazzo ThomasSell1.71K$3.175.42K
2025-04-28Catinazzo ThomasSell981$3.173.11K
2025-04-28Bergstrom Donald ASell4.09K$3.1712.97K
2025-04-28Adams BrianSell1.64K$3.175.21K
2025-04-23Patel SanjivSell42.77K$2.97127.02K
2025-04-23Patel SanjivSell18.65K$2.9755.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 270, holders +22 vs prior quarter. Ownership 122.41%.

HolderSharesChangeChange %Value
SB INVESTMENT ADVISERS (UK) LTD27.90M00.00%522.10M
FMR LLC20.11M16.41M+444.19%376.26M
CASDIN CAPITAL, LLC16.04M1.62M+11.21%300.02M
BLACKROCK, INC.15.29M2.31M+17.83%286.04M
PERCEPTIVE ADVISORS LLC14.11M4.36M+44.66%263.93M
COMMODORE CAPITAL LP12.00M-5.00M-29.41%224.52M
STATE STREET CORP10.13M3.89M+62.43%189.47M
VANGUARD CAPITAL MANAGEMENT LLC8.96M1.58M+21.35%167.72M
PRICE T ROWE ASSOCIATES INC /MD/7.71M5.78M+300.45%144.23M
NEXTECH INVEST LTD.6.78M1.25M+22.62%126.79M
BELLEVUE GROUP AG6.19M-1.61M-20.64%115.74M
GEODE CAPITAL MANAGEMENT, LLC4.73M1.22M+34.64%88.45M
TCG CROSSOVER MANAGEMENT, LLC4.27M00.00%79.95M
MORGAN STANLEY3.85M2.42M+168.93%72.05M
SIREN, L.L.C.3.65M3.65MNew68.29M
GOLDMAN SACHS GROUP INC3.41M866.84K+34.10%63.78M
WESTFIELD CAPITAL MANAGEMENT CO LP3.34M3.34MNew62.56M
KYNAM CAPITAL MANAGEMENT, LP3.30M1.88M+131.70%61.74M
DIMENSIONAL FUND ADVISORS LP3.13M187.03K+6.36%58.53M
SPRUCE STREET CAPITAL LP2.98M00.00%55.83M
VANGUARD PORTFOLIO MANAGEMENT LLC2.89M1.03M+55.23%54.12M
BAKER BROS. ADVISORS LP2.83M1.67M+143.66%52.89M
BANK OF AMERICA CORP /DE/2.70M757.41K+39.09%50.43M
MPM BIOIMPACT LLC2.42M56.09K+2.38%45.20M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.24M1.57M+235.02%41.89M

Earnings and financials

Relay Therapeutics, Inc. (RLAY) trades at $19.47, with a market cap of $4.27B and a trailing P/E of -11.58. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
008265400030290001381000255460001000700015355000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Relay Therapeutics (RLAY) Financials: Revenue & Earnings

RLAY$19.47+0.63 +3.35%

$4.27B

Market Cap

-11.58

P/E

—

Forward P/E

60

Score

Price History